Abiopharma

🔍 Butcher Thatcher (Executive)

Company: STAR EQUITY HOLDINGS, INC. (STRR)

Report Date: 2025-08-22

Detailed Transactions and Holdings:

• Sold 7,345 shares of Common Stock (Direct)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,714 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F3, F3
• Sold 3,187 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F4, F4

Footnotes:

• F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 21, 2025 (the "Merger Agreement"), by and among Star Equity Holdings, Inc. ("Star"), Hudson Global, Inc. ("Hudson") and HSON Merger Sub, Inc., a wholly owned subsidiary of Hudson ("Merger Sub"), in exchange for .23 shares of Hudson common stock for each share of Star common stock on the effective date of the merger (the "Merger").
• F2: These Restricted Stock Units each represent the right to receive, at settlement, one share of Star common stock. These Restricted Stock Units were assumed by Hudson in the Merger and exchanged for .23 Hudson Restricted Stock Units for each Star Restricted Stock Unit.
• F3: As to this grant, one-third of the Restricted Stock Units vested on March 1, 2024, one-third of the Restricted Stock Units vested on March 1, 2025, and one-third of the Restricted Stock Units are scheduled to vest on March 1, 2026, subject to the Reporting Person continuing to provide service through such date.
• F4: As to this grant, one-third of the Restricted Stock Units vested on March 13, 2025, one-third of the Restricted Stock Units are scheduled to vest on March 13, 2026, and one-third of the Restricted Stock Units are scheduled to vest on March 13, 2027, subject to the Reporting Person continuing to provide service through such date.